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Abstract. hBok is a human pro-apoptotic member of the
Bcl-2 family. By fluorescence in situ hybridization  and in
silico analysis, hBok was found to be located on chromo-
some 2q37.3. Its expression was detected in various or-
gans and several hormonally regulated cancer cells. Ex-
pression of hBok was shown to be upregulated in estro-
gen-dependent breast cancer by estrogen deprivation and
in myocardial cells during hypoxia. Confocal laser scan-
ning microscopy examinations and subcellular fractiona-
tion studies showed that hBok was distributed in both the
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cytosol and intracellular membranes of healthy cells.
Upon overexpression of hBok or stimulation of apopto-
sis, hBok became integrated into the membrane. Further-
more, apoptosis and oligomerization were promoted by
BH3-only proteins, such as Bid, Bnip3 and p53, but pre-
vented by BFL-1. hBok was found to interact with Bnip3.
Our findings suggest that functional BH3-only proteins
facilite the oligomerization and insertion of hBok into the
membrane to activate it.
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Introduction
The Bcl-2 family proteins are crucial regulators of apop-
tosis, in which they exert direct control through the release
of apoptogenic factors, such as cytochrome c, to activate
the proteolytic caspase cascade [1]. In mammalian cells,
at least 20 different Bcl-2-related proteins have already
been identified [2, 3]. Based on functional studies and the
retention of BH (‘Bcl-2 homology’) domains, the Bcl-2
family is divided into three subgroups: (i) the Bcl-2 sub-
group, containing more than one BH domain, including all
anti-apoptotic proteins, such as Bcl-2, Bcl-xL, A1/Bfl-1
* Corresponding authors.
and Mcl-1; (ii) the Bax subgroup consisting of multi-BH
domain pro-apoptosis members, such as Bax, Bak, Bok
and Bcl-rambo [4–6]; (iii) the third subgroup containing
BH3-only proteins, such Bid and Bim, which can interact
with either anti-apoptotic proteins or pro-apoptosis mem-
bers and promote apoptosis [4 ].
BH3-only proteins are important in facilitating oligomer-
ization of Bax and Bak leading to pore formation in 
the mitochondrial membrane allowing the release of 
cytochrome c [7–9]. Bax has also been reported to kill
cells by a caspase-independent mechanism [10]. Although
knockout studies in mice revealed that inactivation of 
either bax or bak alone has little consequence, while
elimination of both genes dramatically impairs develop-
mental apoptosis in many tissues [11], recent studies have
shown that in some tissues, the activation of Bak requires
Bax [12]. These results suggest that the regulation of Bax
and Bak interaction may not be simply redundant [13].
The existence of other members of the Bax subfamily 
further implies that modulation of apoptosis may be con-
trolled by more than one mechanism [14 ]. Indeed, recent
studies revealed that oligomerization of both Bax and
Bak could be stimulated by p53, but the latter can only 
interact with Bak [15] and not with Bax [16]. Therefore,
p53 functions also as a BH3-only-like protein.
The mechanisms of action of other multi-domain proteins,
such as Bok, and their contribution to the developmental
susceptibility of apoptosis have not yet been established.
The human Bok gene (hBok) has been identified together
with its rat and mouse counterparts, rBok and Mtd [4, 5,
17]. Rat Bok was shown to be expressed exclusively in 
reproductive tissues [4]. In this study, we show that hBok
originally identified in human granulosa cells is expressed
more widely in other tissues. We have further characterized
the expression and regulation of human Bok. We also 
investigated in detail both the activation of human Bok
and its mode of action.
Materials and methods
Chromosomal localization of hBok by fluorescence in
situ hybridization and partial sequencing
The molecular cloning of hBok was described previously
with the GenBank accession number AF174487 [5]. A P1
DNA was isolated by PCR screening of P1 Human 
Libraries (Genome Systems, St. Louis, M.) with 
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primers 5¢-CCTCGCGGGTCTGAATGGAAGG-3¢ and
5¢-CGAGCGGTCAAAGGCGTCCAT-3¢ according to the
manufacturer’s recommended protocol and sequenced
partially. Fluorescence in situ hybridization (FISH) was
performed on human metaphase chromosomes. The bok
PAC DNA probe was labeled with digoxigenin-11-dUTP
using a nick translation kit (Roche, Basel, Switzerland),
and ethanol-precipitated with salmon sperm DNA and
Escherichia coli tRNA as described previously [18]. 
Hybridization and detection of fluorescence signals were
performed accordingly. Fluorescence images were ob-
served by an Olympus BX-60 epifluorescence micro-
scope with Olympus filter (Olympus, Tokyo, Japan) set
U-MWIB (excitation at 460–490 nm), U-MSWG
(480–550 nm) and U-MWU (330–385 nm). Thegene was
located to human chromosome 2q37.2 using a query of
the sequence to the NCBI STS database and the Human,
Mouse Genome Browser program. PCP was used to 
determine the sizes of introns.
Plasmid constructions
The original PCR products amplified from human gran-
ulosa cDNA were cloned in the EcoRI/NotI site of vector
pZero-1 (Invitrogen, Groningen, The Netherlands) and
sequenced [5]. An EST clone (IMAGE 32090) was also
obtained from the collection of the IMAGE Consortium.
Full-length hBok cDNA was further subcloned into the
pLEGFP-c1 vector (Clontech, Palo Atlo, LA, USA) in the
HindIII/BamHI site. Forward and reverse primers are listed
in table 1. The constructs were confirmed by sequencing.
Table 1.  PCR primers used to generate fragments for hBok constructs and to detect mouse Bcl2-related gene expression
PCR product size 
(bp)
GFP-hBok F 5¢-TCTCGAGCAAGCTTGAATTCTATGGAGGTGCTGC 636
GGCGCTCCTCGGT-3¢
R 5¢-CGGGATCCTCATCTCTCTGGCAGCAGCACGAAG-3¢
hBok F 5¢-CCTCGCGGGTCTGAATGGAAGG-3¢ 164
R 5¢-CGAGCGGTCAAAGGCGTCCAT-3¢
mBok F 5¢-CTCCCTCACTCAAATTGGGA-3¢ 267
R 5¢-ACTGAGGCCAGCTCATGTCT-3¢
mNip3 F 5¢-GGGTTTTCCCCAAAGGAATA-3¢ 179
R 5¢-GACCACCCAAGGTAATGGTG-3¢
mBad F 5¢-TTCCAGATCCCAGAGTTTG-3¢ 488
R 5¢-GGAGATCACTGGGAGGGGGTGG-3¢
mNoxa F 5¢-CGTCGGAACGCGCCAGTGAACCC-3¢ 335
R 5¢-TCCTTCCTGGGAGGTCCCTTCTTGC-3¢
mBmf F 5¢-CCCTTGGGGAGCAGCCCCCTG-3¢ 218
R 5¢-CAAGACAGTATCTGTCCTCCCAGAC-3¢
mBcl2L10 F 5¢-TGAGGAAGTCCTCCAGCCTA-3¢ 240
R 5¢-GCAGCTCAAGAACCCAGAAC-3¢
F, 5¢-forward primer-3¢; R, 5¢-reverse primer-3¢
Cell culture, treatment and cell viability assay
The MCF-7, HEK293 or Hela cells were grown in full
medium (RPMI 1640 or DMDM, Gibco, Basel, Switzer-
land) supplemented with 10% heat-inactivated fetal
bovine serum (Gibco) in 5% CO2, at 37°C, according to
the ATCC recommendation. For estrogen deprivation,
MCF-7 cells were washed three times with PBS then 
further cultured in DMEM with 10% charcoal/dextran-
treated FBS (Hyclone, Logan, UT, USA) for 48 h. This
time point served as a 0 hour time point control. Cells
were either further cultured for 10 h or 50 nM 17 b-estra-
diol (E2) was added for various times before harverst. To
mimic the hypoxia condition, 500 mM CoCl2 was applied
to 2¥105 MCF-7 or HEK293 cells for the indicated times.
To study apoptosis, HEK293 cells or the transfectants
were incubated with 100 nM staurosporine for 12 h. Via-
bility was determined at various time points by trypan
blue exclusion, counting at least 100 cells from each in-
dividual culture. The percentage of cell survival was cal-
culated as the number of surviving cells per total cell
count [19].
Tissue expression pattern analysis by RT-PCR
To determine the expression patterns of Bok mRNA in
different human tissues, PCR was performed using the
primers listed in table 1 on a panel of first-strand cDNAs
from various human tissues (Origene, Rockville, Md.).
The PCR conditions were as described in the manufac-
turer’s protocol with 30 cycles performed on the b-actin
control employing Taq polymerase. To examine the ex-
pression of members of the Bcl-2 family in mouse, mouse
hearts were dissected from two animals. Each dissected
mouse heart was divided into two parts and incubated in
either 21% O2 (normoxic condition) or 1% O2 (hypoxic
condition) for 24 h. Total RNA was purified and normal-
ized by determination of concentration at 260 nm. On mi-
crogram of RNA was used for reverse transcription. PCR
was performed using the primers listed in table 1 with 28
cycles. b-Actin served as a control.
Immunohistochemical investigations
Biopsies were taken following a study protocol approved
by the Ethics Committee of the University Hospital in
Basel. Briefly, cryostat-frozen sections were fixed in 3%
paraformaldehyde followed by application of normal 
rabbit serum (Vector, Burlingame, Calif.). The slides
were then incubated with the primary antibody (1:50
polyclonal rabbit anti-Bok, Sc11424; Santa Cruz, Calif.)
overnight at 4°C. After one wash, specimens were
blocked with avidin (Zymed, San Francisco, Calif.) then
with biotin (Zymed). The sections were incubated with
biotinylated goat anti-rabbit IgG antibody (Vector). They
were then washed again and incubated with a peroxidase
block (Zymed), and reacted with the ABC Elite Kit 
(Vector). 3,30-Diaminobenzidine tetrahydrochloride tablets
(Sigma, Deisenhofen, Germany) were added under light
protection. The reaction was then stopped with PBS. 
Sections were counterstained with hemalum, transferred
to tap water, dehydrated and mounted in Pertex (Medite,
Nunningen, Switzerland).
Cellular fractionation and Western blotting
Cells were pelleted and suspended in 100 ml of an enzy-
matic reaction buffer [19], supplemented with protease
inhibitors and lysed by sonication for 15 s in an ice bath.
The lysate was centrifuged for 10 min at 1000 g for 
removal of unlysed cells and nuclei. The supernatant was
then centrifuged for 1 h at 100,000 g (Kontron Instruments,
Munich, Germany). The final supernatant served as a 
cytosolic fraction, the pellet as a crude membrane frac-
tion which was resuspended in one volume of the 
lysis buffer with 10% Triton X-100. The protein concen-
tration of both cytosolic and membrane fractions was 
determined by a BioRad protein assay (BioRad, Hercules,
CA, USA).
Alkali extraction of membrane proteins was as decribed
previously [20]. Briefly, the membrane fraction was
resuspended (1 mg protein/ml) in freshly prepared 0.1 M
Na2CO3 (pH 11.5) and incubated for 20 min on ice. The
membranes were then pelleted by centrifugation. Mem-
brane proteins corresponding to 20 µg protein were sepa-
rated by 15% SDS-PAGE  (BioRad) and verified using
anti-Bok antibody Sc11424 (Santa Cruz).
To determine oligomerization of hBok, the mitochondrial-
enriched fraction was suspended in isotonic HIM buffer
[21]. Briefly, bismaleim-idohexane (Pierce, Rockford IL,
USA) was added to the membrane fraction from a tenfold
stock solution (in dimethyl sulfoxide) to a final concen-
tration of 10 mM. After incubation for 30 min at room
temperature, the cross-linker was quenched by the addi-
tion of 1 M Tris-HCl, pH 7.5, to a final concentration of
20 mM. After quenching, the samples were lysed and an-
alyzed by Western blot with an anti-Bok antibody
Sc11424 (Santa Cruz).
Fractionated cell lysates were boiled for 10 min. Samples
(20 mg) were separated on 15% SDS-PAGE, electrotrans-
ferred to an Immobilon-P membrane (Millipore, Biller-
ica, MA, USA), immunoblotted with a rabbit polyclonal
anti-His antibody (Milan Analytica, Milan, Italy) or 
anti-Bok antibody (Santa Cruz), and developed with
NBT/BCIP (Sigma, St. Louis, Mo.). 
Subcellular localization of hBok proteins
To examine the subcellular localization of endogenous
hBok, 105 MCF-7 cells were seeded on sterile glass cover-
slips. After 12 h culture with or without 100 nM stau-
rosporine or 50 nM epothilone B (Novartis, Basel,
Switzerland), cells were washed with PBS and fixed with
4% paraformaldehyde (in 10 mM PIPES, 2 mM MgCl2,
2 mM KCl, 300 mM sucrose and 2 mM EGTA). Cells
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were further quenched with 20 mM NH4Cl and perme-
abilized in 0.25% Triton X-100. A rabbit anti-Bok antibody
(Sc-11424; Santa Cruz) was used as primary antibody at
1:200 dilution. The secondary antibody was Alexa-488-
conjugated goat anti-rabbit IgG at 1:1000 dilution. To 
examine the subcellular localization of transfected hBok,
HEK293 or Hela cells were transfected with 0.3 mg of 
expression plasmids encoding GFP-hBok using Effectene
reagent (Qiagen, Hilden, Germany). Cells were incubated
with 100 nM Mitotracker Red 580 (Molecular Probes,
Eugene, Ore.) and then fixed in 3.7% formaldehyde 24 h
post-transfection. The results were further confirmed by
a rabbit polyclonal antibody against Bok BH3 domain
(AP1310a; Abgent, San Diego, Calif.). Images were ac-
quired with a confocal microscope (Leica NT SP1; Leica,
Heidelberg, Germany) with oil immersion using a ¥63
lens on a Leica DM RxE. The images were acquired with
Leica confocal software with the image format of 1024 ¥
1024 pixels ¥ 8 bit, and transferred to a graphics program
for printing.
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Figure 1. Genomic organization and chromosomal localization of the human Bok gene (hBok). (A) Schematic representation of the hBok
gene structure. The boxes represent the exons. The exon numbers are indicated below the boxes. The thin lines denote introns and flanking
regions. The lower panel shows the alignment of the conserved 5 ¢-UTR sequences of human (–371to –709) and mouse (–477 to –821) Bok
genes. Underlines represent transcriptional factor-binding sites. (B) Left panel shows that in situ hybridization of a biotin-labeled human
Bok probe to human metaphase cells resulted in specific labeling on chromosome 2 (arrow). Right panel shows results of FISH mapping.
The detailed position of the Bok gene, on human chromosome 2q37.3, was determined from careful analysis of 40 metaphase cells and
compared to the NCBI STS database.
A
B
Co-immunoprecipitation analysis
HEK293 cells (106 ) were transfected with 1 mg of the 
expression plasmids pcDNA3-his-tBid, pcDNA3-his-Bnip3
and pc53-SN3 encoding Bid, Bnip3 and p53, respectively.
Twenty-four hours after transfection, cells were lysed in
M-PER protein extraction reagent (Pierce). His-Bind
resin (50 ml; Novagen, San Diego, CA, USA) or 5 mg of
anti-p53 (Ab-6) antibody (Oncogene, Cambridge, MA,
USA) were incubated with 100 ml cell lysate. Protein G-
fast Flow Sepharose (25 ml; Amersham, Uppsala, Swe-
den) was added to collect the anti-p53 antibody. The gels
were collected after washing and boiled in SDS sample
buffer followed by SDS-PAGE and Western blot with
anti-Bok antibody (Sc-11424, Santa Cruz).
Results
Isolation and characterization of the human 
Bok gene (hBok)
To identify the chromosomal location of the Bok gene, we
isolated and identified one positive PAC clone, which
covers all coding regions of the human Bok gene from a
human P1 genomic library (see Materials and methods).
Sequence analysis revealed that it contains four coding
exons in which the exon-intron organization is conserved
between human, mouse and rat genes, but the intron sizes
are different between these species (fig. 1A). The complete
Bok gene spanned about 23 kb of genomic DNA. We 
then used this PAC clone as a probe for FISH studies. We
examined chromosomes in metaphase from a normal
male for fluorescence signals. Out of 40 metaphases 
examined, 32 possessed a specific signal in the region
2q37 (fig. 1B). No background signals were observed.
Localization to 2q37 is consistent with in silico analysis
of the draft human DNA sequence at the National Center
for Biotechnology Information, which mapped the 
genomic locus of hBok in human chromosome 2 between
the markers D2S125 and chr2_qTEL. Together with 
all other data, the Bok gene was localized on human 
chromosome 2q37.3 (fig. 1B, right panel).
Differential expression of hBok in human tissues
Semiquantitative RT-PCR analysis (semi-Q-RT-PCR)
was performed using a pair of primers corresponding to
sequences flanking the first intron (Materials and meth-
ods). As shown in figure 2A, human Bok was expressed
mainly in colon, stomach, testis, placenta, pancreas,
ovary and uterus. The expression in fetal liver exhibited a
higher level than that in adult tissue. The expression of
the human Bok protein in various human tissues was also
examined with immunohistochemistry. Figure 2B shows
the localization of hBok protein in ovarian and testicular
tissue samples. Human Bok was expressed predominantly
in the granulosa cell compartment of ovarian follicles,
consistent with the observation for rBok [4], and in the
spermatocytes of testicular seminiferous tubules.
The expression was further examined in various hormon-
ally regulated cancer cell lines using semi-Q-RT-PCR. All
seven breast cancer cell lines displayed much lower Bok
expression than HBL100, which is considered a non-
metastatic breast epithelial cell line. In contrast, granulosa
cell tumors lacked mRNA expression. However, clearcut
expression of Bok mRNA was detected in some other
CMLS, Cell. Mol. Life Sci. Vol. 62, 2005 Research Article 1019
Figure 2. Expression of hBok mRNA species varies in different 
tissues. (A) PCR was performed on a panel of first-strand cDNAs
prepared from different human tissues (Origene). The PCR products
obtained from each reaction following 30 cycles were separated on
a 1.2% agarose gel and visualized by SYBR green I. (B) The local-
ization of hBok protein was examined with immunohistochemistry
in ovarian follicles (A, B) and testicular seminiferous tubules (C,
D). G, granulosa cells; TE, theca cells; arrows, spermatocytes. (C).
hBok expression was examined in various cancer cell lines using
semi-Q-RT-PCR.
A
B
C
A
B
C
D
cancer cells, such as bladder and prostate cancer cells
(fig. 2C).
Differential regulation of hBok expression
During our initial studies on the regulaton of apoptosis in
hormonally regulated breast cancer cell lines, we observed
that hBok expression was enhanced in MCF-7 cells both
by E2 withdrawal and by hypoxia. MCF-7 cells showed
low but detectable levels of hBok mRNA. Cells  cultured
in an estrogen-free, serum-free medium for 2 days or
treated with the steroidal anti-estrogen, ICI 182780, gener-
ated increased levels of hBok mRNA, whereas E2 treat-
ment induced the downregulation of hBok mRNA
(fig. 3A). In contrast, c-Myc expression was increased by
addition of E2 (data not shown). Furthermore, the expres-
sion in MCF-7 cells treated with various concentrations
of CoCl2, a condition which was chosen to mimic hy-
poxia, resulted in increased hBok expression after 24 h.
However, combined treatment of ICI 182780 and hypoxia
did not further enhance the expression of hBok. Similar
observations were made with HEK293 cells (data not
shown). Although staurosporine induced apoptosis in
both cell lines, expression of hBok was not enhanced (fig.
3B), indicating that expression of hBok is regulated dis-
tinctively upon apoptotic stimuli.
Hypoxia has been shown previously to induce brain injury
and apoptosis of cardiomyocytes, resulting in ischemia,
and this process is, at least in part, preventable by estrogen
[22, 23]. We therefore further examined the expression of
Bok in mouse hearts. As demonstrated in figure 3C, Bok
was expressed at very low levels in primary cells, but 
hypoxia caused a significant increment in Bok mRNA
level after 24 h. The expression level of Bnip3 was also
observed to be increased, as Bnip3 has already been 
reported as a hypoxia-response gene during hypoxia-
induced apoptosis [24]. The expression of three other
BH3-only genes was also examined under the same con-
dition: the expression of Bad was decreased, whereas that
of Noxa [25] and Bmf [26] remained unexpressed and that
of Bcl2L10 [27, 28] increased (fig. 3D). Thus, hypoxia
appears to regulate expression of Bok both in the human
and mouse. Examination of the hBok promoter region 
revealed the existence of two conserved Hif-1a binding
sites (fig. 1A). These results suggest that the expression
of Bok may be specifically hypoxia regulated in certain
organs.
Death signals alter the subcellular localization 
of hBok
We first assayed localization of hBok by subcellular frac-
tionation studies. Cells were lysed and fractionated into a
cytosolic and a membrane fraction after removal of the
low-speed nuclear pellet. As shown in figure 4A, the
endogenous hBok protein could be detected in both 
cytosolic and membrane fractions upon subcellular frac-
tionation of healthy MCF-7, wherease Bax was detected
mainly in the cytosolic fraction [29]. Similar results were
obtained in HEK293 and Hela cells lysed in a buffer with
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Figure 3. Regulation of hBok mRNA expression in various conditions studied by semi-Q-RT-PCR. (A) MCF-7 cells were cultured in an 
estrogen (E2)-free, serum-free medium for 48 h. 10 h indicates further culture for 10 h in the estrogen-free medium (-E2) or addition of 
50 nM E2 for 3 or 9 h. (B) Expression of hBok mRNA was examined in 2¥105 MCF7 cells treated with 500 mM CoCl2 for the indicated
times. Expression of hBok mRNA was also examined in HEK293 cells after treatment with 100 nM staurosporine (STS). (C) Examination
of Bok expression in dissected mouse hearts from two animals. Each dissected mouse heart was divided into two parts and incubated in 
either 21% O2 condition (–, normaxia) or 1% O2 (+, hypoxia). Total RNA was normalized by determination of concentration at 260 nm.
One microgram of RNA was used for reverse transcription. As controls, the expression of Bnip3 and the housekeeping gene b-actin were
examined in parallel. (D) Expression of four members of the Bcl2 family, Bad, Noxa, Bmf and Bcl2L10 were examined in the same 
condition as in C.
A
B
C
D
or without detergent (data not shown). Moreover, an alkali
treatment was effective in extracting hBok from the 
membrane, indicating that in healthy cells, Bok appears 
to associate only weakly with the membranes (fig. 4A).
However, after treatment of the cells with various apoptotic
stimuli, the membrane-bound hBok could not be released
by alkali treatment, indicating that hBok had become 
intergrated into the membrane (fig. 4B). Furthermore, we
assessed the subcellular localization of hBok by confocal
laser scanning microscopy. In MCF-7 cells, the expression
of endogenous hBok was rather diffuse thoughout the
cell, examined using two different anti-Bok antibodies
(fig. 4C). However, the distribution of hBok became 
localized together with the membrane when cells were
treated with staurosporine (fig. 4C) or epothilone B (not
shown). Moreover, the full-length hBok was fused to a
GFP expression vector. As shown in figure 4D, the 
experiment of transient overexpression of hBok in Hela
cells revealed that hBok was mainly associated with 
mitochondria, as it was localized very strongly with the
mitochrondial marker. Similar results were found in
HEK293 cells. These results suggest that in healthy cells,
hBok is associated loosely with the membrane in a 
hit-and-run mode. The insertion and accumulation of
hBok on membranes is then enhanced through the activity
of death signals, resulting in the integration of the 
membrane-bound hBok protein into the membrane. 
Oligomerization of hBok is promoted 
by apoptotic stimuli
Bnip3 and p53 were induced or accumulated together
with hBok during hypoxia (fig. 3) [24] and because
Bnip3, p53 and hBok share several properties, such as
their common cytoplasmic and mitochondrial localization
and their pro-apoptotic function, we explored the possibil-
ity of a functional co-operation of these proteins during
apoptosis. Similar to the staurosporine treatment, co-
expression of Bid [20] and Bnip3 further sensitized cells
to apoptosis, which could be counteracted by expression
of BFL-1 (data not shown). Furthermore, oligomerization
of hBok was detected in all transfectants with Bnip3, Bid
and p53, indicating that these BH3-only proteins were
able to induce oligomerization of hBok, as seen with
staurosporine treatment (fig. 5A). However, p53 was not
able to further increase the level of apoptosis under hBok
overexpression (data not shown). Next, we explored the
mode of action of Bnip3, Bid and p53 by examining their
interaction with the endogenous Bok by co-immunopre-
cipitation. HEK293 cells were transfected with His-Bnip3,
p53 or His-Bid (Materials and methods). Cellular lysates
of transfectants were incubated with anti-His or anti-p53
antibodies for pull-down assay. hBok was then detected
by anti-Bok antibody. As shown in figure 5B, hBok could
only be detected in Bnip3 interaction. However, p53 and
Bid could not be detected. These results indicate that hBok
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Figure 4. Intracellular localization of hBok. (A) Subcellular localiza-
tion of Bok by cell fractionation. 5¥106 MCF-7 cells were collected,
lysed and fractionated for high-speed cytosolic and membrane frac-
tions as described in Materials and methods. The protein samples
were separated by 15% SDS-PAGE and analyzed by Western blot
with a polyclonal antibody against human Bok (Santa Cruz) or Bax
(BD/Pharmingen). The proteins were fractionated into cytosolic (1)
and membrane (2) fractions. 3 indicates alkaline-treated membrane
fractions. (B) MCF-7 cells were treated with 100 nM staurosporine
for 12 h. Cell lysates were prepared and analysed as in A. (C) 
Immunolocalization of endogenous hBok in MCF-7 cells treated
with or without 100 nM staurosporine. Micrograph showing a single,
confocal image plane of MCF-7 cells labeled with a rabbit anti-Bok
antibody (Sc-11424) followed by an Alexa-Fluor-488-conjugated
secondary antibody (green). (D) Subcellular localization of GFP-Bok
by confocal microscopy with a magnification of ¥63. Hela cells
were transiently transfected at GFP-Bok as described in Materials
and methods. MitoTracker was used to label mitochondria (mito). 
A
B
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interacts with Bnip3 but not with p53 or Bid directly, 
suggesting that regulation of hBok activation is mediated,
at least in part, by two distinct mechanisms. 
Discussion
The present studies demonstrate that the function of Bok
during apoptosis is regulated both at the transcriptional
and at the post-transcriptional level. In both rat and
mouse, the expression of Bok is almost entirely restricted
to reproductive tissues [4]. Although human Bok is 
expressed in human ovarian granulosa cells and has been
reported to be expressed in pronucleate oocytes [30], 
expression of human hBok mRNA was detected outside
the reproductive organs and found in many tissues, 
suggesting that human Bok may play a more important
role in homeostasis and development than in the rat or
mouse. Indeed, expression is higher in fetal than in adult
liver, suggesting a functional role for hBok in the 
function of that organ during fetal development.
We also demonstrated that the expression of hBok is regu-
lated by only certain apoptotic stimuli, such as estrogen
withdrawal and hypoxia. In accordance with our observa-
tions, a recent study showed that DNA damage induces
expression of Bok in neuroblastoma cells [31]. However,
the treatment of breast cancer cells with staurosporine
was not able to stimulate the expression of Bok, indicating
that regulation of Bok expression may vary according 
to the type of apoptotic signal. Sequence analysis on 
promoter regions of the human, mouse and rat Bok gene
revealed a highly conserved region which contains two
Hif-1a-binding sites. Further experiments are underway
to investigate the function of Hif-1a in the regulation of
Bok. How does the induction of Bok during estrogen de-
privation and hypoxia relate to the initiation of apoptosis?
Bik, a BH3-only protein, could be induced by estrogen
deprivation [32]. Bnip3, another BH3-only protein, is also
induced by hypoxia [24]. One possibility for the initiation
of apoptosis is that activation of Bok is triggered by distinct
BH3-only proteins, such as Bnip3 or Bik. Knock-down
experiments by short interfering RNAs (siRNA) to Bok
will facilitate analysis of the role Bok plays in the apop-
totic pathway triggered by estrogen deprivation and hy-
poxia.
Like many members of the Bcl-2 family, hBok possesses
a hydrophobic COOH-terminal domain. hBok can be
readily isolated from both the membrane and the cytosolic
fraction in healthy cells and it could also be released by
alkali treatment, indicating that it is not an integral mem-
brane protein, which distinguishes it from Bcl-xL and
Bak, which are [33], or Bax, which resides primarily in
the cytoplasm of healthy cells [25, 34]. The hydrophobic
COOH-terminal residues of Bax and Bcl-w form a helix
that creates a hydrophobic groove, into which a BH3 
domain may bind [35, 36]. A domain that encompasses
the hydrophobic helices H6 and H7 of Bid (a cytosolic
protein that lacks the hydrophobic C-terminal domain) is
the minimal region necessary for strong mitochondrial-
binding activity [37, 38]. Furthermore, the acidic phos-
pholipid cardiolipin is the receptor for Bid [39]. All these
observations lead us to speculate that there is a domain
beside the COOH terminus responsible for the weak
membrane association of hBok. Further study should 
investigate this issue.
The weak association of hBok with the mitochondrial
membranes of healthy cells is dramatically altered in 
dying cells, where hBok becomes firmly integrated into
the membrane. Several studies have shown that damage
signals induce the expression of a BH3 domain-only 
protein, which then replaces the hydrophobic COOH-
terminal helix, causing the translocation of Bax from the
cytosol to mitochondrial membranes, where it forms
oligomers [8, 11, 40, 41].
Interestingly, our co-immunoprecipitation studies could
only detect the interaction of hBok with His-Bnip3 but
not with p53 and His-Bid, suggesting that the regulation
of hBok activation is mediated, at least in part, by two 
different mechanisms: oligomerization of hBok can be
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Figure 5. Oligomerization of hBok by BH3-like proteins and inter-
action of hBok with Bnip3. (A) Oligomerization of hBok. The
membrane fraction of cell lysates was incubated with 10 mM BMH
cross-linker for 30 min at room temperature. Mitochondrial proteins
were extracted with a Chaps buffer and subjected to SDS-PAGE 
under non-denaturing conditions. Cells were transfected without
(health control) or with the genes indicated or treated with 100 nM
staurosporine (STS). Western blot was performed with a rabbit 
anti-Bok antibody (Sc-11424, Santa Cruz). (B) HEK293 cells were
transfected with Bnip3, p53 or tBid with non-transfected cells as a
control. Western blot was performed with a polyclonal antibody
against human Bok (Sc-11424, Santa Cruz).
triggered directly by Bnip3 but oligomers formed only in
the presence of p53 and Bid via a specific but still 
unknown element. Hypoxia-induced activation of hBok,
Bnip3 and p53 and oligomerization of hBok could be
triggered by Bnip3 and p53, which suggests that these
factors act together. Bnip3 is a BH3-only protein, and 
regulates activation-induced cell death of effector cyto-
toxic T lymphocytes [42]. Bnip3 has previously been
demonstrated to interact with Bcl-2/Bcl-xL [43] and
CD47 [44]. hBok could be another Bnip3-interacting 
protein; the binding activates hBok by triggering its
oligomerization and is thus associated with the initiation
of cell death. Overexpression of Bnip3 alone  has been 
reported to initiate permeability transition pore opening
and induce a necrosis-like cell death [45]. However, many
cellular events, such as hypoxia, are accompanied by
changes in the expression of more than one gene, which
may work co-operatively. Whether the association of
Bnip3 with hBok plays a role in mediating necrotic cell
death remains to be elucidated.
p53 is a key tumor suppressor, which induces cell cycle
arrest, DNA repair and apoptosis. p53 is normally
thought to be localized in the nucleus and to regulate 
numerous p53-responsive genes [46, 47]. However, recent
studies revealed that p53 also has a role in the cytoplasm
and functions as a BH3-like protein during apoptosis 
[15, 16]. Our studies showed that although p53 was 
unable to interact directly with hBok, it was able to activate
hBok by triggering oligomerization. Many pro-apoptotic
Bcl-2-related genes, such as Bax, DR5, Bid, Puma and
Noxa, are p53-dependent target genes [48–51]. HBok has
not been shown to be a direct target of p53, and we could
not exclude some function of nuclear p53 in this study.
Unlike direct p53-Bak interaction [15], p53 could not in-
teract with hBok directly. p53 may sequester Bcl-2/Bcl-xL
to release pro-apoptotic Bcl-2 proteins or BH3-only 
proteins, such as Bnip3, as suggested with Bax [16]. 
At present, our data suggest that the weak binding to the
mitochondrial membrane represents a primary contact in
preparation for activation of apoptosis. Interaction of BH3
domain proteins, such as Bnip3, with hBok induces a 
secondary membrane insertion step resulting in integration
of hBok into the membrane.
Acknowledgements. We are grateful to Prof. Martinou at the 
Departement of Cell Biology, University of Geneva, for providing
us with pcDNA3-His-Bid employed in this study. We are also 
grateful to Prof. Gudat of the Institute of Pathology for assistance
and discussion of immunohistochemical studies.
1 Green D. R. and Kroemer G. (2004) The pathophysiology of
mitochondrial cell death. Science 305: 626–629
2 Cory S. and Adams J. M. (2002) The Bcl2 family: regulators of
the cellular life-or-death switch. Nat. Rev. Cancer 2: 647–656
3 Gross A., McDonnell J. M. and Korsmeyer S. J. (1999) BCL-2 
family members and the mitochondria in apoptosis. Genes Dev.
13: 1899–1911
4 Hsu S. Y., Kaipia A., McGee E., Lomeli M. and Hsueh A. J.
(1997) Bok is a pro-apoptotic Bcl-2 protein with restricted 
expression in reproductive tissues and heterodimerizes with 
selective anti-apoptotic Bcl-2 family members. Proc. Natl.
Acad. Sci. USA 94: 12401–12406
5 Zhang H., Holzgreve W. and De Geyter C. (2000) Evolutionarily
conserved Bok proteins in the Bcl-2 family. FEBS Lett. 480:
311–313
6 Kataoka T., Holler N., Micheau O., Martinon F., Tinel A., 
Hofmann K. et al. (2001 ) Bcl-rambo, a novel Bcl-2 homologue
that induces apoptosis via its unique C-terminal extension. J.
Biol. Chem. 276: 19548–19554
7 Kuwana T., Mackey M. R., Perkins G., Ellisman M. H., Latterich
M., Schneiter R. et al. (2002) Bid, Bax, and lipids cooperate to
form supramolecular openings in the outer mitochondrial
membrane. Cell 111: 331–342
8 Antonsson B., Montessuit S., Sanchez B. and Martinou J. C.
(2001) Bax is present as a high molecular weight oligomer/
complex in the mitochondrial membrane of apoptotic cells. J.
Biol. Chem. 276: 11615–11623
9 Roucou X., Montessuit S., Antonsson B. and Martinou J. C.
(2002) Bax oligomerization in mitochondrial membranes 
requires tBid (caspase-8-cleaved Bid) and a mitochondrial 
protein. Biochem. J. 368: 915–921
10 Knudson C. M., Tung K. S., Tourtellotte W. G., Brown G. A.
and Korsmeyer S. J. (1995) Bax-deficient mice with lymphoid
hyperplasia and male germ cell death. Science. 270: 96–99
11 Lindsten T., Ross A. J., King A., Zong W. X., Rathmell J. C.,
Shiels H. A. et al. ( 2000 ) The combined functions of
proapoptotic Bcl-2 family members bak and bax are essential
for normal development of multiple tissues. Mol. Cell. 6:
1389–1399
12 Mikhailov V., Mikhailova M., Degenhardt K., Venkatachalam
M. A., White E. and Saikumar P. (2003) Association of Bax and
Bak homo-oligomers in mitochondria: Bax requirement for
Bak reorganization and cytochrome c release. J. Biol. Chem.
278: 5367–5376.
13 Gillissen B., Essmann F., Graupner V., Starck L., Radetzki S.,
Dorken B. et al. (2003) Induction of cell death by the BH3-only
Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-
dependent mitochondrial pathway. EMBO J. 22: 3580–3590
14 Xiang J., Zhao D. T. and Korsmeyer S. J. (1996) Bax-induced
cell death may not require interleukin 1b-converting enzyme-like
proteases. Proc. Natl. Acad. Sci. USA 93: 14559–14563
15 Leu J. I., Dumont P., Hafey M., Murphy M. E. and George D. L.
(2004) Mitochondrial p53 activates Bak and causes disruption
of a Bak-Mcl1 complex. Nat. Cell Biol. 5: 443–450
16 Chipuk J. E., Kuwana T., Bouchier-Hayes L., Droin N. M.,
Newmeyer D. D., Schuler M. et al. (2004) Direct activation of
Bax by p53 mediates mitochondrial membrane permeabilization
and apoptosis. Science 303: 1010–1014
17 Inohara N., Ekhterae D., Garcia I., Carrio R., Merino J., Merry
A. et al. (1998) Mtd, a novel Bcl-2 family member activates
apoptosis in the absence of heterodimerization with Bcl-2 and
Bcl-XL. J. Biol. Chem. 273: 8705–8710
18 Sauter G., Moch H., Carroll P., Kerschmann R., Mihatsch M. J.
and Waldman F. M. (1995) Chromosome-9 loss detected by 
fluorescence in situ hybridization in bladder cancer. Int. J. 
Cancer 64: 99–103
19 Zhang H., Heim J. and Meyhack B. (1998) Redistribution of
Bax from cytosol to membranes is induced by apoptotic stimuli
and is an early step in the apoptotic pathway. Biochem. 
Biophys. Res. Commun. 251: 454–459
20 Eskes R., Desagher S., Antonsson B. and Martinou J. C. (2000)
Bid induces the oligomerization and insertion of Bax into 
the outer mitochondrial membrane. Mol. Cell Biol. 20: 929–
935
21 Grinberg M., Sarig R., Zaltsman Y., Frumkin D., Grammatikakis
N., Reuveny E. et al. (2002) tBID homooligomerizes in the 
CMLS, Cell. Mol. Life Sci. Vol. 62, 2005 Research Article 1023
mitochondrial membrane to induce apoptosis. J. Biol. Chem.
277: 12237–12245
22 Harms C., Lautenschlager M., Bergk A., Katchanov J., Freyer
D., Kapinya K. et al. (2001) Differential mechanisms of neuro-
protection by 17 beta-estradiol in apoptotic versus necrotic 
neurodegeneration. J. Neurosci. 21: 2600–2609
23 Kim Y. D., Chen B., Beauregard J., Kouretas P., Thomas G.,
Farhat M. G. et al. (1996) 17 beta-estradiol prevents dysfunc-
tion of canine coronary endothelium and myocardium and
reperfusion arrhythmias after brief ischemia/reperfusion. Cir-
culation 94: 2901–2908
24 Bruick R. K. (2000) Expression of the gene encoding the
proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl.
Acad. Sci. USA 97: 9082–9087
25 Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita
T. et al . ( 2000 ) Noxa, a BH3-only member of the Bcl-2 family
and candidate mediator of p53-induced apoptosis. Science 288:
1053–1058
26 Puthalakath H., Villunger A., O’Reilly L. A., Beaumont J. G.,
Coultas L., Cheney R. E. et al (2001) Bmf: a proapoptotic BH3-
only protein regulated by interaction with the myosin V actin
motor complex, activated by anoikis. Science 293: 1829–1832.
27 Inohara N., Gourley T. S., Carrio R., Muniz M., Merino J., 
Garcia I. et al. (1998) Diva, a Bcl-2 homologue that binds 
directly to Apaf-1 and induces BH3-independent cell death. J.
Biol. Chem. 273: 32479–32486
28 Zhang H., Holzgreve W. and De Geyter C. (2001) Bcl2-L-10, a
novel anti-apoptotic member of the Bcl-2 family, blocks 
apoptosis in the mitochondria death pathway but not in the
death receptor pathway. Hum. Mol. Genet. 10: 2329–2339
29 Hsu Y. T., Wolter K. G. and Youle R. J. (1997) Cytosol-to-
membrane redistribution of Bax and Bcl-X(L) during apoptosis.
Proc. Natl. Acad. Sci. USA 94: 3668–3672
30 Metcalfe A. D., Helen R. H., Debra J. B., Brian A. L., Helen M.
P., Henry J. L. et al ( 2004) Expression of 11 members of the
BCL-2 family of apoptosis regulatory molecules during human
preimplantation embryo development and fragmentation. Mo.l
Reprod. Dev. 68: 35–50
31 Yakovlev A. G., Di Giovanni S., Wang G., Liu W., Stoica B. and
Faden A. I. (2004) Bok and Noxa are essential mediators of
p53-dependent apoptosis. J. Biol. Chem. 279: 28367–28374
32 Hur J., Chesnes J., Coser K. R., Lee R. S., Geck P., Isselbacher K.
J. et al. (2004) The Bik BH3-only protein is induced in estrogen-
starved and antiestrogen-exposed breast cancer cells and 
provokes apoptosis. Proc. Natl. Acad. Sci. USA 101: 1829–1832
33 Kaufmann T., Schlipf S., Sanz J., Neubert K., Stein R. and
Borner C. (2003) Characterization of the signal that directs 
Bcl-x(L), but not Bcl-2, to the mitochondrial outer membrane.
J. Cell. Biol. 160: 53–64
34 Putcha G. V., Deshmukh M. and Johnson E. M. Jr. (1999) BAX
translocation is a critical event in neuronal apoptosis: regulation
by neuroprotectants, BCL-2, and caspases. J. Neurosci. 19:
7476–7485
35 Sattler M., Liang H., Nettesheim D., Meadows R. P., Harlan J.
E., Eberstadt M. et al. (1997) Structure of Bcl-xL-Bak peptide
complex: recognition between regulators of apoptosis. Science
275: 983–986
36 Petros A. M., Olejniczak E. T. and Fesik S. W. (2004) Structural
biology of the Bcl-2 family of  proteins. Biochim. Biophys.
Acta 1644: 83–94 
37 Desagher S., Osen-Sand A. and Nichols A. (1999) Bid-induced
conformational change of Bax is responsible for mitochondrial
cytochrome c release during apoptosis. J. Cell Biol. 144:
891–901
38 Hu X., Han Z., Wyche J. H. and Hendrickson E. A. (2003) 
Helix 6 of tBid is necessary but not sufficient for mitochondrial
binding activity. Apoptosis 8: 277–289
39 Lutter M., Fang M., Luo X., Nishijima M., Xie X. and Wang X.
(2000) Cardiolipin provides  specificity for targeting of tBid to
mitochondria. Nat. Cell Biol. 10: 754–761
40 Nechushtan A., Smith C. L., Hsu Y. T. and Youle R. J. (1999)
Conformation of the Bax C-terminus regulates subcellular 
location and cell death. EMBO J. 18: 2330–2341
41 Nechushtan A., Smith C. L., Lamensdorf I., Yoon S. H. and
Youle R. J. (2001) Bax and Bak coalesce into novel mitochondria-
associated clusters during apoptosis. J. Cell Biol. 153: 1265–
1276
42 Wan J., Martinvalet D., Ji X., Lois C., Kaech S. M., Von Andrian
U. H. et al. (2003) The Bcl-2 family pro-apoptotic molecule,
BNIP3 regulates activation-induced cell death of effector 
cytotoxic T lymphocytes. Immunology 110: 10–17
43 Ray R., Chen G., Vande Velde C., Cizeau J., Park J. H., Reed J.
C. et al. (2000) BNIP3 heterodimerizes with Bcl-2/Bcl-X(L)
and induces cell death independent of a Bcl-2 homology 3
(BH3) domain at both mitochondrial and nonmitochondrial
sites. J. Biol. Chem. 275: 1439–1448
44 Lamy L., Ticchioni M., Rouquette-Jazdanian A. K., Samson
M., Deckert M., Greenberg A. H. et al. (2003) CD47 and the 
19 kDa interacting protein-3 (BNIP3) in T cell apoptosis. J.
Biol. Chem. 278: 915–921
45 Vande Velde C., Cizeau J., Dubik D., Alimonti J., Brown T., 
Israels S. et al. (2000) BNIP3 and genetic control of necrosis-
like cell death through the mitochondrial permeability transition
pore. Mol Cell Biol. 20: 5454–5468
46 Liang S. H. and Clarke M. F. (2001) Regulation of p53 local-
ization. Eur. J. Biochem. 268: 2779–2783
47 Fei P., Bernhard E. J. and El-Deiry W. S. (2002) Tissue-specific
induction of p53 targets in vivo. Cancer Res. 62: 7316–7327
48 Miyashita T. and Reed J. C. (1995) Tumor suppressor p53 is a
direct transcriptional activator of the human bax gene. Cell 80:
293–299
49 Sax J. K., Fei P., Murphy M. E., Bernhard E., Korsmeyer S. J.
and El-Deiry W. S. (2002) BID regulation by p53 contributes to
chemosensitivity. Nat. Cell Biol. 4: 842–849
50 Villunger A., Michalak E. M., Coultas L., Mullauer F., Bock G.,
Ausserlechner M. J. et al. (2003) p53- and drug-induced apop-
totic responses mediated by BH3-only proteins puma and noxa.
Science 302: 1036–1038
51 Sheikh M. S., Burns T. F., Huang Y., Wu G. S., Amundson S.,
Brooks K. S. et al. (1998) p53-dependent and -independent reg-
ulation of the death receptor KILLER/DR5 gene expression in
response to genotoxic stress and tumor necrosis factor alpha.
Cancer Res. 58: 1593–1598
1024 S. Gao et al. Activation of hBok by Bnip3
